Trademark: 97715158
Word
BRYLEOS
Status
Pending
Status Code
688
Status Date
Tuesday, January 2, 2024
Serial Number
97715158
Mark Type
4000
Filing Date
Tuesday, December 13, 2022
Published for Opposition
Tuesday, November 7, 2023

Trademark Owner History
BioNADrx Holdings, Inc. - Owner At Publication

Classifications
5 Pharmaceutical preparations for humans and animals for the prevention and treatment of neurologic, cardiovascular, dermatologic, inflammatory, immunologic, neuromuscular, reproductive, pancreatic, metabolic, hepatic, inflammatory, psychiatric, and orthopedic diseases, disorders, and conditions; Pharmaceutical preparations for humans and animals for the prevention and treatment of substance use disorder and substance withdrawal; Pharmaceutical preparations for humans and animals for use in treating and managing diseases, disorders, and conditions relating to aging; Therapeutic preparations for humans and animals, namely, therapeutic pharmaceutical preparations for the treatment and prevention of intracellular NAD depletion; Therapeutic preparations for humans and animals, namely, therapeutic pharmaceutical preparations for replenishing coenzyme depletion; Therapeutic agents for humans and animals for regulation of gene expression in aging and metabolic disease, nutrient sensing, and inflammasome suppression
1 Chemicals for use in agriculture, horticulture, and botany, except fungicides, herbicides, insecticides, and parasiticides; Chemical preparations for use in agriculture, horticulture, and botany, namely, chemical preparations for managing growth, health, and sustainability of plants except fungicides, herbicides, insecticides, and parasiticides; Substances for regulating growth in plants; Chemical preparations to prevent and treat diseases affecting rooted plants
42 Research and development in the fields of human and veterinary pharmaceuticals, intracellular NAD depletion, aging, and aging-related diseases, disorders, and conditions for humans and animals; Providing medical scientific information in the fields of human and veterinary pharmaceuticals, intracellular NAD depletion, aging, and aging-related diseases, disorders, and conditions for humans and animals

Trademark Events
Jan 2, 2024
Noa E-Mailed - Sou Required From Applicant
Nov 7, 2023
Official Gazette Publication Confirmation E-Mailed
Nov 7, 2023
Published For Opposition
Oct 18, 2023
Notification Of Notice Of Publication E-Mailed
Oct 2, 2023
Approved For Pub - Principal Register
Oct 2, 2023
Examiner's Amendment Entered
Oct 2, 2023
Notification Of Examiners Amendment E-Mailed
Oct 2, 2023
Examiners Amendment E-Mailed
Oct 2, 2023
Examiners Amendment -Written
Sep 27, 2023
Teas/Email Correspondence Entered
Sep 26, 2023
Correspondence Received In Law Office
Sep 26, 2023
Teas Response To Office Action Received
Sep 18, 2023
Notification Of Non-Final Action E-Mailed
Sep 18, 2023
Non-Final Action E-Mailed
Sep 18, 2023
Non-Final Action Written
Sep 18, 2023
Assigned To Examiner
Jan 10, 2023
New Application Office Supplied Data Entered
Dec 16, 2022
New Application Entered

Trademark Alertz updated from USPTO on 2030-01-24